Crossmark

Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12885-026-15818-5

Published Online: 2026-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Liang

Mao, Wu

Deng, Hua

Zhou, Wei-ping

Zhang, Liang

Li, Jie
License Information

Text and Data Mining valid from 2026-03-10

Version of Record valid from 2026-04-16
More Information

Article History

Received: 7 November 2025

Accepted: 26 February 2026

First Online: 10 March 2026

Declarations

:

: The study was approved by the Ethics Committee of the People’s Liberation Army General Hospital (No. S2025-398-01). It was conducted in accordance with the ethical standards established by the Helsinki Declaration. Informed consent was obtained from all participants included in the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below